A new pill to treat HIV infection — combining two previously approved drugs with two new ones — has been approved for adults living with the virus that causes AIDS, US regulators said yesterday.
The single daily dose of Stribild provides a complete treatment regimen for HIV infection, the US Food and Drug Administration (FDA) said and is meant for people who have not already received treatment with other HIV drugs.
“Through continued research and drug development, treatment for those infected with HIV has evolved from multi-pill regimens to single-pill regimens,” said Edward Cox, director of the Office of Antimicrobial Products in the FDA’s Center for Drug Evaluation and Research. “New combination HIV drugs like Stribild help simplify treatment regimens.”
The new pill, made by Gilead Sciences in California, was tested in more than 1,400 patients, in two double-blind clinical trials.
Results showed that Stribild performed as well or better than two other treatment combinations, and brought virus readings down to undetectable levels in around nine of 10 patients after 48 weeks.
“Therapies that address the individual needs of patients are critical to enhancing adherence and increasing the potential for treatment success,” Gilead chief John Martin said in the statement.
This is Gilead’s third single-tablet anti-HIV combination therapy, the company noted, adding that it is still seeking approval for the newest offering in Australia, Canada and the EU.
To get the drug to HIV patients in the developing world, where millions lack access to effective treatment options, generic versions are being developed — with permission and help from Gilead — by a number of Indian manufacturers and the Medicines Patent Pool, a non-profit group that helps facilitate generic drug-making.
The drug combines Truvada — another Gilead offering approved in 2004, that combines emtricitabine and tenofovir disoproxil fumarate to fight an enzyme that HIV needs to replicate — with elvitegravir, another enzyme-fighting drug and cobicistat, which enhances the effects of elvitegravir.
The FDA said further study is needed to ascertain the quad-drug’s safety for women and children, how resistance may develop and whether the drug interacts with other drugs.
Stribild will also be required to carry a label warning patients and health care providers the drug can cause fatal side effects, including severe liver problems and a build-up of lactic acid in the blood. The FDA said the label is also required for many other HIV-fighting drugs.
However, Gilead said that during the studies, “most adverse effects were mild to moderate.”
The FDA said patients commonly experienced nausea and diarrhea. The drug also weakened bones and caused or worsened kidney problems — both of which will be mentioned in a warning on the drug’s label. Truvada was previously approved as a treatment for people infected with HIV to be used in combination with other antiretroviral drugs.
POLITICAL PATRIARCHS: Recent clashes between Thailand and Cambodia are driven by an escalating feud between rival political families, analysts say The dispute over Thailand and Cambodia’s contested border, which dates back more than a century to disagreements over colonial-era maps, has broken into conflict before. However, the most recent clashes, which erupted on Thursday, have been fueled by another factor: a bitter feud between two powerful political patriarchs. Cambodian Senate President and former prime minister Hun Sen, 72, and former Thai prime minister Thaksin Shinawatra, 76, were once such close friends that they reportedly called one another brothers. Hun Sen has, over the years, supported Thaksin’s family during their long-running power struggle with Thailand’s military. Thaksin and his sister Yingluck stayed
Kemal Ozdemir looked up at the bare peaks of Mount Cilo in Turkey’s Kurdish majority southeast. “There were glaciers 10 years ago,” he recalled under a cloudless sky. A mountain guide for 15 years, Ozdemir then turned toward the torrent carrying dozens of blocks of ice below a slope covered with grass and rocks — a sign of glacier loss being exacerbated by global warming. “You can see that there are quite a few pieces of glacier in the water right now ... the reason why the waterfalls flow lushly actually shows us how fast the ice is melting,” he said.
FOREST SITE: A rescue helicopter spotted the burning fuselage of the plane in a forested area, with rescue personnel saying they saw no evidence of survivors A passenger plane carrying nearly 50 people crashed yesterday in a remote spot in Russia’s far eastern region of Amur, with no immediate signs of survivors, authorities said. The aircraft, a twin-propeller Antonov-24 operated by Angara Airlines, was headed to the town of Tynda from the city of Blagoveshchensk when it disappeared from radar at about 1pm. A rescue helicopter later spotted the burning fuselage of the plane on a forested mountain slope about 16km from Tynda. Videos published by Russian investigators showed what appeared to be columns of smoke billowing from the wreckage of the plane in a dense, forested area. Rescuers in
‘ARBITRARY’ CASE: Former DR Congo president Joseph Kabila has maintained his innocence and called the country’s courts an instrument of oppression Former Democratic Republic of the Congo (DR Congo) president Joseph Kabila went on trial in absentia on Friday on charges including treason over alleged support for Rwanda-backed militants, an AFP reporter at the court said. Kabila, who has lived outside the DR Congo for two years, stands accused at a military court of plotting to overthrow the government of Congolese President Felix Tshisekedi — a charge that could yield a death sentence. He also faces charges including homicide, torture and rape linked to the anti-government force M23, the charge sheet said. Other charges include “taking part in an insurrection movement,” “crime against the
RSS